• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Mergers & Acquisitions

PerkinElmer to acquire Oxford Immunotec

January 7, 2021 By Sean Whooley

PerkinElmer (NYSE:PKI) and Oxford Immunotec announced today that they agreed to terms under which the former will acquire the latter. Under the agreement, London-based Oxford Immunotec’s shareholders will be entitled to receive $22 for each outstanding ordinary share, with the terms of the acquisition valuing Oxford Immunotec’s entire issued and to-be-issued ordinary share capital at $591 […]

Filed Under: Business/Financial News, Diagnostics, Drug-Device Combinations, Featured, Mergers & Acquisitions, Respiratory Tagged With: Oxford Immunotec, perkinelmer

Evonik buys polymers business from Durect Corp.

January 5, 2021 By Nancy Crotti

Evonik said today that it has acquired the Lactel PLGA-based polymers business from Durect Corp. All Durect employees associated with the Lactel business in Birmingham, Ala., accepted the offer to join Evonik in similar roles, according to Essen, Germany-based Evonik. The deal closed Dec. 31, 2020. Evonik will integrate the Lactel biodegradable polymers line into its […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions Tagged With: Durect Corp., Evonik

BREAKING: Thermo Fisher drops bid for Qiagen

August 13, 2020 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that its offer to acquire Qiagen (NYSE:QGEN) in an $11.5 billion deal has lapsed. According to a news release, more than 107.5 million shares of Qiagen (47.02% of the issued and outstanding ordinary shares for the company) were validly tendered into the offer by the end of the acceptance period on Aug. […]

Filed Under: Business/Financial News, Diagnostics, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: qiagen, thermofisherscientific

Lantheus, Progenics complete merger

June 22, 2020 By Sean Whooley

lantheus-logo

Lantheus Medical Imaging (NSDQ:LNTH) parent company Lantheus Holdings announced the completion of its merger with Progenics Pharmaceuticals. Progenics, an oncology company developing medicines and artificial intelligence-based technologies for finding, fighting and following cancer, entered into a merger agreement with Lantheus that was first announced on Oct. 2, 2019. Get the full story at our sister site, MassDevice.

Filed Under: Business/Financial News, Diagnostics, Featured, Mergers & Acquisitions, Oncology, Pharmaceuticals Tagged With: Lantheus, Progenics

Kindeva Drug Delivery launches as independent company from 3M

May 4, 2020 By Danielle Kirsh

kindeva-drug-delivery

Kindeva Drug Delivery recently announced that it launched as an independent company, shedding its former 3M Drug Delivery Systems name. The formation of the independent company follows its acquisition by Altaris Capital Partners in a transaction that was worth $650 million. Through the acquisition, 3M will hold a 17% minority interest in Kindeva with Altaris. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions Tagged With: 3M, 3M Drug Delivery Systems, Kindeva Drug Delivery

3M to sell drug-delivery biz to Altaris Capital Partners for $650m

December 12, 2019 By Sean Whooley

3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for approximately $650 million. St. Paul, Minn.-based 3M will retain its transdermal drug delivery components business, according to a news release. The business being divested has annual global sales reaching approximately […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions Tagged With: 3M

Glaukos completes Avedro buy

November 21, 2019 By Danielle Kirsh

Glaukos logo

Glaukos (NYSE:GKOS) today said it completed its acquisition of Avedro for an undisclosed amount. Avedro develops single-use drug formulations that are designed to strengthen corneal tissues and stop the progression of degenerative corneal ectatic disease keratoconus. “Today marks an important day for Glaukos as Avedro will serve as the cornerstone of our new corneal health franchise,” […]

Filed Under: Featured, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Avedro Inc., Glaukos

Haselmeier licenses Axis-D pen injector to Stevanato Group

October 7, 2019 By Sean Whooley

Haselmeier said today that it entered into an exclusive agreement with Stevanato Group to license the Axis-D pen injector and intellectual property for the development, manufacturing and supply of the device for diabetes care. Haselmeier’s Axis-D auto-injector pen is approved for use by the European Medical Agency and the FDA, among other regulatory bodies. The […]

Filed Under: Auto-injectors, Diabetes, Featured, Mergers & Acquisitions Tagged With: haselmeier, Stevanato Group

LifeScan inks deal to broker institutional sales for OneTouch Reveal Plus

October 2, 2019 By Sean Whooley

LifeScan OneTouch app

LifeScan said yesterday that it entered into an agreement with Willis Towers Watson to expand the commercialization of its OneTouch Reveal Plus digital diabetes therapy system. The companies hope the collaboration will see LifeScan and Willis Towers Watson combine to support self-insured employers in helping their employees and dependents manage diabetes. The OneTouch Reveal Plus […]

Filed Under: Diabetes, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: lifescan, welldoc

Nemaura, Sparsha ink drug-delivery deal

September 27, 2019 By Sean Whooley

Nemaura Pharma said today that it entered into a strategic collaboration with Sparsha Pharma USA for the development and manufacturing of transdermal drug delivery systems. The terms of the agreement state that Loughborough, England-based Nemaura will develop transdermal therapeutic systems at its facilities in the U.K., up to pilot clinical manufacture, for both global pharmaceutical […]

Filed Under: Drug-Device Combinations, Featured, Mergers & Acquisitions Tagged With: Nemaura Pharma, Sparsha Pharma

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS